IL-17 抗体
(Interleukin 17 (IL17))
The protein encoded by this gene is a proinflammatory cytokine produced by activated T cells. This cytokine regulates the activities of NF-kappaB and mitogen-activated protein kinases. This cytokine can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| IL-17 抗体 (AA 35-130) (Cy5) | 人 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 35-130) (Cy5.5) | 人 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 35-130) (Cy7) | 人 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 35-130) (AbBy Fluor® 680) | 人 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 35-130) (AbBy Fluor® 350) | 人 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 35-130) (Cy3) | 人 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 35-130) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 85-150) (Cy5.5) | 大鼠 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 85-150) (PE) | 大鼠 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 85-150) (HRP) | 大鼠 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 85-150) (Biotin) | 大鼠 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 85-150) (Cy3) | 大鼠 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 85-150) (Cy5) | 大鼠 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 85-150) (Cy7) | 大鼠 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (PE-Cy7) | 大鼠 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (PE-Cy5) | 大鼠 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (PE-Cy5.5) | 大鼠 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 85-150) (AbBy Fluor® 555) | 大鼠 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 85-150) (AbBy Fluor® 350) | 大鼠 | 兔 Polyclonal |
|
|
|
| IL-17 抗体 (AA 85-150) (AbBy Fluor® 750) | 大鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5
- 抗体亚型
- IgG
- 抗原表位
- AA 35-130
Primary Antibody
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5.5
- 抗体亚型
- IgG
- 抗原表位
- AA 35-130
Primary Antibody
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy7
- 抗体亚型
- IgG
- 抗原表位
- AA 35-130
Primary Antibody
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 680
- 抗体亚型
- IgG
- 抗原表位
- AA 35-130
Primary Antibody
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 350
- 抗体亚型
- IgG
- 抗原表位
- AA 35-130
Primary Antibody
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 35-130
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 35-130
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5.5
- 抗体亚型
- IgG
- 抗原表位
- AA 85-150
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 85-150
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 85-150
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 85-150
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 85-150
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5
- 抗体亚型
- IgG
- 抗原表位
- AA 85-150
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy7
- 抗体亚型
- IgG
- 抗原表位
- AA 85-150
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE-Cy7
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE-Cy5
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE-Cy5.5
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 555
- 抗体亚型
- IgG
- 抗原表位
- AA 85-150
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 350
- 抗体亚型
- IgG
- 抗原表位
- AA 85-150
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 750
- 抗体亚型
- IgG
- 抗原表位
- AA 85-150
Latest Publications for our IL-17 抗体
: "Once-monthly hemin suppresses inflammatory and autoreactive CD4+ T cell responses to robustly ameliorate experimental rheumatoid arthritis." in: iScience, Vol. 24, Issue 10, pp. 103101, (2021) (PubMed).
: "Therapeutic effectiveness of type I interferon in vulvovaginal candidiasis." in: Microbial pathogenesis, Vol. 134, pp. 103562, (2020) (PubMed).
: "Recombinant Sj16 protein with novel activity alleviates hepatic granulomatous inflammation and fibrosis induced by Schistosoma japonicum associated with M2 macrophages in a mouse model." in: Parasites & vectors, Vol. 12, Issue 1, pp. 457, (2020) (PubMed).
: "Role of CD200/CD200R Signaling Pathway in Regulation of CD4+T Cell Subsets During Thermal Ablation of Hepatocellular Carcinoma." in: Medical science monitor : international medical journal of experimental and clinical research, Vol. 25, pp. 1718-1728, (2019) (PubMed).
: "Interleukin‑17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages." in: Molecular medicine reports, Vol. 19, Issue 6, pp. 4743-4752, (2019) (PubMed).
: "Effect of IL-17 in the development of colon cancer in mice." in: Oncology letters, Vol. 12, Issue 6, pp. 4929-4936, (2017) (PubMed).
: "Effects of 1,25-dihydroxyvitamin D3 in an ovalbumin-induced allergic rhinitis model." in: International immunopharmacology, Vol. 47, pp. 182-189, (2017) (PubMed).
: "Identification of hub genes and pathways associated with bladder cancer based on co-expression network analysis." in: Oncology letters, Vol. 14, Issue 1, pp. 1115-1122, (2017) (PubMed).
: "Promoting effects of IL‑23 on myocardial ischemia and reperfusion are associated with increased expression of IL‑17A and upregulation of the JAK2‑STAT3 signaling pathway." in: Molecular medicine reports, Vol. 16, Issue 6, pp. 9309-9316, (2017) (PubMed).
: "Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma." in: Oncology letters, Vol. 14, Issue 1, pp. 561-568, (2017) (PubMed).
: "Therapeutic effectiveness of type I interferon in vulvovaginal candidiasis." in: Microbial pathogenesis, Vol. 134, pp. 103562, (2020) (PubMed).
: "Recombinant Sj16 protein with novel activity alleviates hepatic granulomatous inflammation and fibrosis induced by Schistosoma japonicum associated with M2 macrophages in a mouse model." in: Parasites & vectors, Vol. 12, Issue 1, pp. 457, (2020) (PubMed).
: "Role of CD200/CD200R Signaling Pathway in Regulation of CD4+T Cell Subsets During Thermal Ablation of Hepatocellular Carcinoma." in: Medical science monitor : international medical journal of experimental and clinical research, Vol. 25, pp. 1718-1728, (2019) (PubMed).
: "Interleukin‑17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages." in: Molecular medicine reports, Vol. 19, Issue 6, pp. 4743-4752, (2019) (PubMed).
: "Effect of IL-17 in the development of colon cancer in mice." in: Oncology letters, Vol. 12, Issue 6, pp. 4929-4936, (2017) (PubMed).
: "Effects of 1,25-dihydroxyvitamin D3 in an ovalbumin-induced allergic rhinitis model." in: International immunopharmacology, Vol. 47, pp. 182-189, (2017) (PubMed).
: "Identification of hub genes and pathways associated with bladder cancer based on co-expression network analysis." in: Oncology letters, Vol. 14, Issue 1, pp. 1115-1122, (2017) (PubMed).
: "Promoting effects of IL‑23 on myocardial ischemia and reperfusion are associated with increased expression of IL‑17A and upregulation of the JAK2‑STAT3 signaling pathway." in: Molecular medicine reports, Vol. 16, Issue 6, pp. 9309-9316, (2017) (PubMed).
: "Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma." in: Oncology letters, Vol. 14, Issue 1, pp. 561-568, (2017) (PubMed).
Aliases for IL-17 抗体
interleukin 17A (IL17A) 抗体interleukin 17A (Il17a) 抗体
ChIL-17 抗体
Ctla-8 抗体
CTLA-8 抗体
CTLA8 抗体
Ctla8 抗体
IL-17 抗体
IL-17A 抗体
IL-17F 抗体
IL17 抗体
Il17 抗体
IL17A 抗体
您还需要查找其他产品吗？
You are here:
